Bank of Montreal’s Editas Medicine EDIT Stock Holding History

Bank of Montreal’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,300	Closed	-$55K	–	3585
2021 Q3	$55K	Buy	+1,300	New	+$71.2K	﹤0.01%	3545

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Bank of Montreal's EDIT Position: Q2 2023 in Review

Bank of Montreal sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 12,370 shares — an estimated $91.8K sold.

Bank of Montreal first reported a position in EDIT in Q3 2016 and held it in 24 quarters. The position peaked at $1.01M in Q1 2022. 238 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

Bank of Montreal reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
Bank of Montreal sold 12,370 Editas Medicine shares in Q2 2023, an estimated $91.8K.
Bank of Montreal first reported a position in Editas Medicine in Q3 2016 and held it in 24 quarters.
Bank of Montreal's Editas Medicine position peaked at $1.01M in Q1 2022.
238 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.